These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19171155)

  • 41. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
    Rong L; Perelson AS
    PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.
    Rong L; Perelson AS
    Math Biosci; 2009 Jan; 217(1):77-87. PubMed ID: 18977369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels.
    Sörstedt E; Nilsson S; Blaxhult A; Gisslén M; Flamholc L; Sönnerborg A; Yilmaz A
    BMC Infect Dis; 2016 Jun; 16():305. PubMed ID: 27329293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential implication of residual viremia in patients on effective antiretroviral therapy.
    Sahu GK
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):25-35. PubMed ID: 25428885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.
    Bachmann N; von Siebenthal C; Vongrad V; Turk T; Neumann K; Beerenwinkel N; Bogojeska J; Fellay J; Roth V; Kok YL; Thorball CW; Borghesi A; Parbhoo S; Wieser M; Böni J; Perreau M; Klimkait T; Yerly S; Battegay M; Rauch A; Hoffmann M; Bernasconi E; Cavassini M; Kouyos RD; Günthard HF; Metzner KJ;
    Nat Commun; 2019 Jul; 10(1):3193. PubMed ID: 31324762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stochastic modelling of viral blips in HIV-1-infected patients: effects of inhomogeneous density fluctuations.
    Sánchez-Taltavull D; Alarcón T
    J Theor Biol; 2015 Apr; 371():79-89. PubMed ID: 25681146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamics of an HIV Model with Multiple Infection Stages and Treatment with Different Drug Classes.
    Wang X; Song X; Tang S; Rong L
    Bull Math Biol; 2016 Feb; 78(2):322-49. PubMed ID: 26842389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of new antiretroviral therapy in HIV infected patients with virologic failure].
    Costagliola D
    Med Sci (Paris); 2012; 28(8-9):706-7. PubMed ID: 22920871
    [No Abstract]   [Full Text] [Related]  

  • 49. MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.
    Blankson JN; Siliciano RF
    J Clin Invest; 2001 Mar; 107(5):549-51. PubMed ID: 11238554
    [No Abstract]   [Full Text] [Related]  

  • 50. The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.
    ; Marcotullio S; Andreoni M; Antinori A; d'Arminio Monforte A; Di Perri G; Galli M; Ippolito G; Perno CF; Rizzardini G; Lazzarin A; ; Cinque P; Fares G; Foglia E; Gervasoni C; Murri R; Nozza S; Rusconi S
    New Microbiol; 2012 Jul; 35(3):259-77. PubMed ID: 22842596
    [No Abstract]   [Full Text] [Related]  

  • 51. Residual Viremia in Treated HIV+ Individuals.
    Conway JM; Perelson AS
    PLoS Comput Biol; 2016 Jan; 12(1):e1004677. PubMed ID: 26735135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Density-dependent decay in HIV-1 dynamics.
    Holte SE; Melvin AJ; Mullins JI; Tobin NH; Frenkel LM
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):266-76. PubMed ID: 16540927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy.
    Sánchez-Taltavull D; Vieiro A; Alarcón T
    J Math Biol; 2016 Oct; 73(4):919-46. PubMed ID: 26921201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preventing rebound viremia after ending ART. Long-term control].
    Bischoff A
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():10. PubMed ID: 25026845
    [No Abstract]   [Full Text] [Related]  

  • 55. Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy.
    Dijkstra S; Hofstra LM; Mudrikova T; Wensing AMJ; Oomen PGA; Hoepelman AIM; van Welzen BJ
    J Acquir Immune Defic Syndr; 2022 Apr; 89(5):575-582. PubMed ID: 34966148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection.
    Crowell TA; Pinyakorn S; Sacdalan C; Kroon E; Colby DJ; Puttamaswin S; Ubolyam S; Trichavaroj R; Butterworth O; Turk E; Mccullough C; Chomont N; de Souza M; Robb ML; Phanuphak N; Ananworanich J;
    Clin Infect Dis; 2020 Jun; 70(12):2706-2709. PubMed ID: 31550044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.
    Fischer M; Joos B; Niederöst B; Kaiser P; Hafner R; von Wyl V; Ackermann M; Weber R; Günthard HF
    Retrovirology; 2008 Nov; 5():107. PubMed ID: 19036147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of ART-induced viral suppression on the HIV epidemic in Italy.
    Papa F; Felici G; Franzetti M; Gandolfi A; Sinisgalli C
    Math Med Biol; 2020 May; 37(2):183-211. PubMed ID: 31162541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased inflammation in sanctuary sites may explain viral blips in HIV infection.
    Cardozo EF; Piovoso MJ; Zurakowski R
    IET Syst Biol; 2016 Aug; 10(4):153-66. PubMed ID: 27444025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients.
    Conway JM; Coombs D
    PLoS Comput Biol; 2011 Apr; 7(4):e1002033. PubMed ID: 21552334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.